Compare Ingersoll Rand (IR) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ingersoll Rand vs Tenet Healthcare Corporation — how do they compare? Ingersoll Rand trades at $71.61 (market cap $27.90B), while Tenet Healthcare Corporation trades at $265.48 (market cap $21.00B). The key difference: Ingersoll Rand is the larger of the two by market cap, and Ingersoll Rand pays a 0.11% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| IR | THC | |
|---|---|---|
Market Cap | $27.90B | $21.00B |
Volume | 5,665,729 | 518,734 |
Sector | Industrials | Health |
52-Week High | $98.76 | $280.77 |
52-Week Low | $68.54 | $161.37 |
Enterprise Value | $31.56B | $32.08B |
Dividend Yield | 0.11% | — |
Typical Hold Time | — | 13 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ingersoll Rand (IR) trades at $71.91, down 1.4% today, amid a bearish technical signal. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $0.86 surpassing the $0.827 forecast. Revenue guidance for 2026 was raised to 4.5%-6.5% growth, though margins faced compression. The stock shows strong analyst support with a consensus price target of $95.33 and no sell ratings among 15 analysts.
The outlook is positive given earnings momentum and raised guidance, but high valuation (P/E 29.81) and technical bearishness pose near-term risks. Profitability improvements in 2026 and institutional accumulation offer upside, while margin pressures and economic sensitivity require monitoring.
Tenet Healthcare (THC) trades at $260.85, down 1.08% today, with a bullish technical signal from moving averages and strong analyst support. The stock shows robust fundamentals, including a P/E of 10.22, net income margin of 9.9%, and three consecutive quarterly EPS beats. Recent news highlights growth prospects, such as a $2.0 billion senior notes offering for refinancing (Business Wire, 2026-09-08).
Outlook remains positive with an 81.25% buy rating from analysts and a $281.44 consensus price target, implying upside. Risks include debt refinancing execution and healthcare sector volatility, but earnings momentum and valuation discounts support long-term potential for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Ingersoll Rand
Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
